EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mitomycin C as a Promising Neoadjuvant Agent in a Case of Giant Ocular Surface Squamous Neoplasia

Ritika Tripathi, Haritha Veluri, Potti Sudhakar, Mariya Farooqui

Journal of Ophthalmology Clinics and Research · 2023-07 · 3 (2) · 31-34

DOI: 10.4103/jocr.jocr_8_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ophthalmology Clinics and Research, online erschienen am 14.07.2026. Verfasst von Ritika Tripathi und 3 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular surface squamous neoplasia (OSSN) represents a spectrum of conjunctival and corneal epithelial malignancies with varied clinical presentations and management strategies. A 64-year-old male presented with a large, painless mass involving the entire anterior surface of the right globe, measuring approximately 30 mm × 30 mm × 10 mm, with restriction of ocular motility temporally. Vision was perception of light in the affected eye (right eye), while the left eye had a best-corrected visual acuity of 6/9 with pseudophakia and posterior capsular opacification. Magnetic resonance imaging revealed a homogeneous T2/STIR hyperintense lesion abutting the lacrimal gland without intraorbital extension, suggestive of a neoplastic etiology. The tumor was clinically staged as T3N0M0. The patient was initiated on topical mitomycin C (MMC) 0.04% four times daily (QID) in a cyclical regimen (2 weeks on, 2 weeks off), resulting in significant and progressive tumor regression. The lesion reduced to 9 mm × 8 mm × 2 mm over 2.5 months, thereby allowing surgical management with wide local excision, cryotherapy, and amniotic membrane grafting. Histopathological examination was consistent with OSSN. This case highlights the significant role of topical MMC in reducing tumor burden in advanced OSSN, facilitating subsequent surgical management and improved clinical outcomes.

Zitieren

APA

Tripathi, R., Veluri, H., Sudhakar, P., & Farooqui, M. (2023). Mitomycin C as a Promising Neoadjuvant Agent in a Case of Giant Ocular Surface Squamous Neoplasia. Journal of Ophthalmology Clinics and Research, 3(2), 31-34. https://doi.org/10.4103/jocr.jocr_8_26

Vancouver

Tripathi R, Veluri H, Sudhakar P, Farooqui M. Mitomycin C as a Promising Neoadjuvant Agent in a Case of Giant Ocular Surface Squamous Neoplasia. Journal of Ophthalmology Clinics and Research. 2023;3(2):31-34. doi:10.4103/jocr.jocr_8_26

BibTeX
@article{Tripathi2023,
  author = {Tripathi, Ritika and Veluri, Haritha and Sudhakar, Potti and Farooqui, Mariya},
  title = {Mitomycin C as a Promising Neoadjuvant Agent in a Case of Giant Ocular Surface Squamous Neoplasia},
  journal = {Journal of Ophthalmology Clinics and Research},
  year = {2023},
  volume = {3},
  number = {2},
  pages = {31--34},
  doi = {10.4103/jocr.jocr_8_26}
}
Kostenlos starten →